137 related articles for article (PubMed ID: 10844099)
1. Facilitation and inhibition by endothelin-1 of adrenal catecholamine secretion in anesthetized dogs.
Hosokawa A; Nagayama T; Yoshida M; Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
Eur J Pharmacol; 2000 May; 397(1):55-61. PubMed ID: 10844099
[TBL] [Abstract][Full Text] [Related]
2. Role of endogenous endothelins in catecholamine secretion in the rat adrenal gland.
Nagayama T; Kuwakubo F; Matsumoto T; Fukushima Y; Yoshida M; Suzuki-Kusaba M; Hisa H; Matsumura Y; Kimura T; Satoh S
Eur J Pharmacol; 2000 Oct; 406(1):69-74. PubMed ID: 11011035
[TBL] [Abstract][Full Text] [Related]
3. Role of ET(B) receptors and nitric oxide in adrenal catecholamine secretion in anesthetized dogs.
Hosokawa A; Nagayama T; Masada K; Yoshida M; Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
Am J Physiol; 1999 Oct; 277(4):R1051-6. PubMed ID: 10516244
[TBL] [Abstract][Full Text] [Related]
4. Role of ET(A) and ET(B) receptors in endothelin-1-induced adrenal catecholamine secretion in vivo.
Yamaguchi N
Am J Physiol; 1997 Apr; 272(4 Pt 2):R1290-7. PubMed ID: 9140032
[TBL] [Abstract][Full Text] [Related]
5. Renal effects of endothelin in anesthetized rabbits.
Ono N; Matsui T; Yoshida M; Suzuki-Kusaba M; Hisa H; Satoh S
Eur J Pharmacol; 1998 Oct; 359(2-3):177-84. PubMed ID: 9832389
[TBL] [Abstract][Full Text] [Related]
6. Endothelin enhances and inhibits adrenal catecholamine release in deoxycorticosterone acetate-salt hypertensive rats.
Lange DL; Haywood JR; Hinojosa-Laborde C
Hypertension; 2000 Jan; 35(1 Pt 2):385-90. PubMed ID: 10642329
[TBL] [Abstract][Full Text] [Related]
7. Potentiation by endothelin-1 of vasoconstrictor response in stroke-prone spontaneously hypertensive rats.
Matsumura Y; Kita S; Okui T
Eur J Pharmacol; 2001 Mar; 415(1):45-9. PubMed ID: 11245851
[TBL] [Abstract][Full Text] [Related]
8. Depressor responses to endothelin-1 into the superior colliculus of rats: predominant role of endothelin ET(B) receptors.
D'Amico M; Di Filippo C; Rossi F
Eur J Pharmacol; 1998 Apr; 347(1):71-5. PubMed ID: 9650850
[TBL] [Abstract][Full Text] [Related]
9. Effects of clentiazem (TA-3090) and nifedipine on basal circulating catecholamine levels and on stimulation-evoked adrenal catecholamine secretion in anesthetized dogs.
Gaspo R; Lamarche L; Yamaguchi N; de Champlain J; Garceau D
Can J Physiol Pharmacol; 1992 Jul; 70(7):983-9. PubMed ID: 1451037
[TBL] [Abstract][Full Text] [Related]
10. Differential inhibition by TAK-044 of the inotropic effects of endothelin-1 and endothelin-3.
Yomogida S; Maruya J; Norota I; Ishii K; Endoh M
Eur J Pharmacol; 2004 May; 492(2-3):217-24. PubMed ID: 15178368
[TBL] [Abstract][Full Text] [Related]
11. Effects of protein kinase C activator and inhibitor on adrenal catecholamine release in response to splanchnic nerve stimulation in anesthetized dogs.
Suzuki Y; Kimura T; Satoh S
J Cardiovasc Pharmacol; 1994 Jul; 24(1):22-7. PubMed ID: 7521485
[TBL] [Abstract][Full Text] [Related]
12. Corelease of neuropeptide Y like immunoreactivity with catecholamines from the adrenal gland during splanchnic nerve stimulation in anesthetized dogs.
Briand R; Yamaguchi N; Gagne J; Kimura T; Farley L; Foucart S; Nadeau R; de Champlain J
Can J Physiol Pharmacol; 1990 Mar; 68(3):363-9. PubMed ID: 2322892
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by omega-conotoxin GVIA of adrenal catecholamine release in response to endogenous and exogenous acetylcholine.
Kimura T; Takeuchi A; Satoh S
Eur J Pharmacol; 1994 Oct; 264(2):169-75. PubMed ID: 7851479
[TBL] [Abstract][Full Text] [Related]
14. Role of nitric oxide in adrenal catecholamine secretion in anesthetized dogs.
Nagayama T; Hosokawa A; Yoshida M; Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
Am J Physiol; 1998 Oct; 275(4):R1075-81. PubMed ID: 9756536
[TBL] [Abstract][Full Text] [Related]
15. Apamin-sensitive SK(Ca) channels modulate adrenal catecholamine release in anesthetized dogs.
Nagayama T; Koshika T; Hisa H; Kimura T; Satoh S
Eur J Pharmacol; 1997 May; 327(2-3):135-41. PubMed ID: 9200551
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms and receptor subtypes involved in the stimulatory action of endothelin-1 on rat adrenal zona glomerulosa.
Rebuffat P; Mazzocchi G; Macchi C; Malendowicz LK; Gottardo G; Nussdorfer GG
Int J Mol Med; 1999 Mar; 3(3):307-10. PubMed ID: 10028057
[TBL] [Abstract][Full Text] [Related]
17. Effects of adrenomedullin and PAMP on adrenal catecholamine release in dogs.
Masada K; Nagayama T; Hosokawa A; Yoshida M; Suzuki-Kusaba M; Hisa H; Kimura T; Satoh S
Am J Physiol; 1999 Apr; 276(4):R1118-24. PubMed ID: 10198393
[TBL] [Abstract][Full Text] [Related]
18. Inhibition by nifedipine of endothelin-induced adrenal catecholamine secretion in anesthetized dogs.
Yamaguchi N
Can J Physiol Pharmacol; 1993; 71(3-4):301-5. PubMed ID: 8402396
[TBL] [Abstract][Full Text] [Related]
19. Correlation between neural release of VIP and adrenomedullary catecholamine secretion in vivo.
Gaspo R; Yamaguchi N; de Champlain J
Am J Physiol; 1995 Jun; 268(6 Pt 2):R1449-55. PubMed ID: 7611521
[TBL] [Abstract][Full Text] [Related]
20. Injection of endothelin-1 into the raphe obscurus of rats induces depressor responses predominantly through endothelin ET(A) receptors.
D'Amico M; Di Filippo C; Esposito F; Rossi F; Filippelli A
Naunyn Schmiedebergs Arch Pharmacol; 1999 Jun; 359(6):471-6. PubMed ID: 10431758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
